Atezolizumab plus chemotherapy and maintenance niraparib in late-relapsing recurrent chemotherapy-sensitive ovarian cancer does not significantly improve outcomes.
Read More
Pembrolizumab added to neoadjuvant and adjuvant chemotherapy improves event-free survival in patients with early triple-negative breast cancer (TNBC).
Read More
Explore, connect, learn, relax and more at the AAO 2023 Expo. Follow PW for conference updates.
Read More
AAO Announces The Orbital 2023: Gold Rush Fundraising Event, formerly the Orbital Gala.
Read More
Hispanic people have a disproportionately high incidence of liver cancer compared with other groups but are under-represented in Phase 3 trials for the disease.
Read More
The growing number of physicians approaching retirement age face a plethora of misinformation pertaining to retirement planning.
Read More
Researchers report higher PrEP use and fewer insurance-related issues from 2019 to 2021, but the Braidwood versus Becerra case could impact these improvements.
Read More
Physicians typically address movement disorders, such as tardive dyskinesia, during in-person examinations; however, a recent study shows that telehealth visits can be a part of treatment plans.
Read More
Providing psychoeducation throughout recovery and rehabilitation from burn injuries may offer opportunities to facilitate access to psychological support.
Read More
A study has found that estimating time to kidney failure in advanced CKD can inform clinical decisions and patient counseling on prognosis.
Read More
A study suggests that continuous gastric artery infusion chemotherapy was effective and safe in relieving digestive obstruction in advanced gastric cancer.
Read More
Medicine and healthcare are complex. Often, patients hear from friends or family members regarding...
Read More
An exercise program for patients with MS that included regular remote coaching improved cardiovascular and respiratory health.
Read More
Physician’s Weekly recently spoke with Linda Girgis, MD, FAAFP, about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
Read More
Patients with tardive dyskinesia being treated with vesicular monoamine transporter 2 inhibitors may see improvement in well-being along with TD symptoms.
Read More
End Hep C SF placed the city on track to achieve the 2030 HCV elimination target set by the WHO among men who have sex with men who have ever injected drugs.
Read More
Known disparities related to race and sex in deceased donor liver transplantation also appear to influence live donor liver transplantation.
Read More
Physician’s Weekly recently spoke with William D. Chey, MD, FACG, AGAF, FACP, RFF, lead author of the phase 3 T3MPO-2 study—which assessed the efficacy of the NHE3 inhibitor tenapanor in treating patients with irritable bowel syndrome with constipation (IBS-C)—about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
Read More
For children with drug-resistant epilepsy, older age at seizure onset and higher HRQOL before surgery were associated with better postoperative HRQOL.
Read More
“Cold and flu” season is nearly here; however, language matters, and I would argue that it’s important to change our lexicon to more accurately reflect the true health risks of the season.
Read More
